We are pursuing this goal through an ambitious mission: to create therapies that enable a patient’s own body to produce the biologics they need—biologics from within—thus eliminating the manufacturing and supply chain costs currently associated with biologics therapy. We believe that our undertaking this mission will provide a superior return to our investors and significant benefit to society.